$PPCH - is pleased that our substantial efforts an

$PPCH - is pleased that our substantial efforts and pioneering research into the effects of proenzymes as a treatment against metastatic cancer have resulted in recognition by the Patent Offices in the US and Europe of the novelty of our claims," said James Nathanielsz, Propanc's Chief Executive Officer. "We will continue to work hard to protect our intellectual property to ensure we deliver maximum long term value to our shareholders," he added.
http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U